1. Li, Ming, Xu, Dongqiang, Zhan, Yijun, Tan, Shiyun. 2022. IPO7 promotes pancreatic cancer progression via regulating ERBB pathway. In Clinics (Sao Paulo, Brazil), 77, 100044. doi:10.1016/j.clinsp.2022.100044. https://pubmed.ncbi.nlm.nih.gov/35588577/
2. Xu, Jin, Xu, Weixue, Xuan, Yang, Sun, Qinyun, Lan, Cheng. 2021. Pancreatic Cancer Progression Is Regulated by IPO7/p53/LncRNA MALAT1/MiR-129-5p Positive Feedback Loop. In Frontiers in cell and developmental biology, 9, 630262. doi:10.3389/fcell.2021.630262. https://pubmed.ncbi.nlm.nih.gov/34660566/
3. Chen, Jing, Hu, Yan, Teng, Yincheng, Yang, BiKang. 2021. Increased Nuclear Transporter Importin 7 Contributes to the Tumor Growth and Correlates With CD8 T Cell Infiltration in Cervical Cancer. In Frontiers in cell and developmental biology, 9, 732786. doi:10.3389/fcell.2021.732786. https://pubmed.ncbi.nlm.nih.gov/34650978/
4. Szczyrba, Jaroslaw, Nolte, Elke, Hart, Martin, Wullich, Bernd, Grässer, Friedrich A. 2012. Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma. In International journal of cancer, 132, 775-84. doi:10.1002/ijc.27731. https://pubmed.ncbi.nlm.nih.gov/22815235/